UBE2I and cancer: Moreover, aberrant expression of UBE2I has been implicated in the development and progression of various human cancers, including breast cancer, gliomas, lung cancer, head and neck squamous cell carcinoma, osteosarcoma, and hepatocellular carcinoma43.